Abstract
The work of Dr. Lenz (this volume) which proved the teratogenic effects of thalidomide in man, has had important consequences for drug evaluation. His work particularly provided a strong stimulus for the development of an international drug monitoring system as a means of preventing future disasters. These efforts started within WHO when the widespread occurrence of thalidomide-damaged babies began to become evident. As my presentation will deal with some experiences of the system which was devised, I will start with a short review of its development.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Böttiger LE, Westerholm B (1973) Drug-induced blood dyscrasias in Sweden. Br Med J 3:339–43
Brown P, Baddeley H, Read AE, Davis JD, Mc Garry J (1974) Sclerosing peritonitis, an unusual reaction to a β-adrenergic-blocking drug (practolol). Lancet 2:1477–81
Brown P, Gajdusek DC, Gibbs CJ Jr, Asher DM (1985) Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 313: 728–31
Griffin JP (1984) Voluntary reporting, in Monitoring for adverse drug reactions. MTP Press, Lancaster, pp 21–30
Liljestrand Å (1984) Voluntary reporting. Discussion. MIT Press, Lancaster, pp 31–34
Nordic Statistics On Medicines (1978–1980) Parts I, II Nordic drug index with classification and defined daily doses. Ill Guidelines for ATC classification. Nordic Council on Medicines, Uppsala 1982
Olsson S, Biriell C, Boman G (1985) Photosensitivity during treatment with azapropazone. Br Med J 291:939
Strieker BHC, Meyboom RHB, Lindquist M (1985) Acute hypersensitivity reactions to paracetamol. Br Med J 291:938–9
Venning GR (1983) Identification of adverse reactions to new drugs. II — How were 18 important adverse reactions discovered and with what delays? Br Med J 286: 289–92
Wright P (1974) Skin reactions to practolol. Br Med J 2: 560
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin, Heidelberg
About this paper
Cite this paper
Liljestrand, Å. (1987). Problems with International Evaluation of Drug Risks. In: Kewitz, H., Roots, I., Voigt, K. (eds) Epidemiological Concepts in Clinical Pharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71043-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-71043-8_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71045-2
Online ISBN: 978-3-642-71043-8
eBook Packages: Springer Book Archive